SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Feb 4, 2020
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Feb. 4, 2020 · CIK: 0001175680 · Accession: 0000000000-20-001068
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236198
Letter
February 4, 2020 Craig Eastwood Chief Financial Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, WA 98660 Re:CytoDyn Inc. Registration Statement on Form S-3 Filed January 31, 2020 File No. 333-236198 Dear Mr. Eastwood: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact William Mastrianna, Attorney-Adviser, at (202) 551-3778 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kara Tatman
Show Raw Text
February 4, 2020
Craig Eastwood
Chief Financial Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, WA 98660
Re:CytoDyn Inc.
Registration Statement on Form S-3
Filed January 31, 2020
File No. 333-236198
Dear Mr. Eastwood:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact William Mastrianna, Attorney-Adviser, at (202) 551-3778 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Kara Tatman